ARTICLE

FindCenter AddIcon

Opening Up the Future of Psychedelic Science

By Thomas Anderson and Rotem Petranker — 2018

There is a growing research literature suggesting psychedelics hold incredible promise for treating mental health ailments ranging from depression and anxiety to PTSD. But how do we know for sure?

Read on theconversation.com

FindCenter Post-Image

My Adventures with the Trip Doctors

My first psilocybin journey began around an altar in the middle of a second-story loft in a suburb of a small city on the Eastern Seaboard.

Article
Michael Pollan
2018
FindCenter AddIcon
FindCenter Post-Image

Crash Course in the Nature of Mind

Roland Griffiths' psilocybin experiments have produced striking evidence for therapeutic uses of hallucinogens.

Article
Julie Scharper
FindCenter AddIcon
FindCenter Post-Image

Are Psychedelics the Answer to Depression and Addiction?

A new generation of research into psilocybin could change how we treat numerous mental health conditions.

Article
Johann Hari
2018
FindCenter AddIcon
FindCenter Post-Image

‘60 Minutes’ Segment Explores Psychedelics Research at Johns Hopkins

Scientists Roland Griffiths and Matthew Johnson sit down with journalist Anderson Cooper to discuss the promise of psychedelics as a form of treatment for anxiety, depression, addiction, and more.

Article
60 Minutes
2019
FindCenter AddIcon
FindCenter Post-Image

Roland Griffiths: 5 Fast Facts You Need to Know

Roland Griffiths is a Johns Hopkins University professor, researcher and expert in the field of pharmacology. He is best known for his research into the beneficial effects psilocybin on cancer patients.

Article
Alyssa Choiniere
2019
FindCenter AddIcon
FindCenter Post-Image

Psilocybin Studies and the Religious Experience: An Interview with Roland Griffiths, Ph.D.

We spoke about his research with psilocybin, his interest in spiritual experiences, and how psychedelics may provide help for people who are dying.

Article
David Jay Brown with Louise Reitman
FindCenter AddIcon
FindCenter Post-Image

Scientists Gave Depressed Patients Psilocybin in a First for Psychedelic Therapy

In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.

Article
Victoria Turk
2016
FindCenter AddIcon
FindCenter Post-Image

We Can No Longer Ignore the Potential of Psychedelic Drugs to Treat Depression

At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.

Article
Robin Carhart-Harris
2020
FindCenter AddIcon
FindCenter Post-Image

Magic Mushrooms Expand the Mind by Dampening Brain Activity

A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.

Article
Maia Szalavitz
2012
FindCenter AddIcon
FindCenter Post-Image

Your Brain on Psilocybin

How magic mushrooms expand consciousness.

Article
Robin Carhart-Harris
2014
FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research